No black box warning on record for Hypothalmapath
As of the latest FDA labeling reviewed, Hypothalmapath (GELSEMIUM, GINKGO, GLYCYRRHIZA, HYDROCOTYLE, HYPOTHALAMUS, PETROSELINUM, PITUITARUM POSTERIUM, PYRIDOXINUM HYDROCHLORICUM, SENNA, SILICEA) does not carry a black box warning. Standard warnings and precautions still apply — see the full Hypothalmapath medicine page for the complete safety profile.